Pfizer Inc. (ETR:PFE)
21.51
-0.38 (-1.71%)
Oct 10, 2025, 5:35 PM CET
Pfizer Employees
Pfizer had 81,000 employees as of December 31, 2024. The number of employees decreased by 7,000 or -7.95% compared to the previous year.
Employees
81,000
Change (1Y)
-7,000
Growth (1Y)
-7.95%
Revenue / Employee
€672,611
Profits / Employee
€113,294
Market Cap
121.21B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 81,000 | -7,000 | -7.95% |
Dec 31, 2023 | 88,000 | 5,000 | 6.02% |
Dec 31, 2022 | 83,000 | 4,000 | 5.06% |
Dec 31, 2021 | 79,000 | 500 | 0.64% |
Dec 31, 2020 | 78,500 | -9,800 | -11.10% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Siemens Healthineers AG | 72,000 |
Merck KGaA | 59,020 |
Bayer Aktiengesellschaft | 91,864 |
Fresenius SE & Co. KGaA | 176,486 |
Fresenius Medical Care AG | 111,513 |
Sartorius Aktiengesellschaft | 13,528 |
Fielmann Group AG | 24,363 |
Carl Zeiss Meditec AG | 5,730 |
Pfizer News
- 17 hours ago - Lower drug prices for Americans! Trump seals deal with AstraZeneca; some medicines at discounts of up to 80% - The Times of India
- 1 day ago - Biotech Stocks Have Struggled Since 2021. Why They're Coming Back. - Barrons
- 1 day ago - AstraZeneca makes deal with Trump to lower drug prices and avoid tariffs - The Guardian
- 1 day ago - AstraZeneca to become latest drugmaker to strike deal with Trump. Its stock is down but outperforming the market. - MarketWatch
- 1 day ago - AstraZeneca to follow Pfizer lead in making drug price deal with Trump - report - Seeking Alpha
- 1 day ago - Pfizer (PFE) Target Price Lowered by Morgan Stanley | PFE Stock News - GuruFocus
- 1 day ago - Trump reaches deal with AstraZeneca to lower U.S. drug prices, MSNBC reports - CNBC
- 1 day ago - FDA Gives Tentative Nod to Sandoz's Generic Version of Pfizer's Inlyta - GuruFocus